Peter P. Lee MD

Dr. Lee is a pioneer in the field of emerging biotechnology, specializing in immunology and the Human Microbiome, with more than 20 years experience in basic and clinical investigations to bring products through the rigorous FDA approval process. Dr. Lee co-founded Osel in order to translate research into commercial products that harness the human microbiome. Dr. Lee is also Billy Wilder Endowed Professor and Chair of Immuno-Oncology at the City of Hope Comprehensive Cancer Center. The inventor of the bioengineered MucoCept technology, he has overseen the development of Osel’s portfolio of LBPs since 2002. A previous faculty member of Stanford University, Dr. Lee trained in hematology and immunology, where his goal has been to utilize the body’s immune system to treat cancer, infections, and other human conditions.

Dr. Lee has published more than 80 articles in peer-reviewed journals and received significant grant awards from the National Institutes of Health, US Department of Defense, and Stand Up To Cancer. He is an elected member of the American Society for Clinical Investigation, and recipient of the Department of Defense Era of Hope Scholar Award, American Cancer Society Research Scholar, and Damon Runyon Scholar Award.